Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.05
—
Mkt Cap $433.77M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+387.8%
Consensus $10.00 vs current $2.05
NASDAQ·Healthcare·Biotechnology
$2.05
—
Mkt Cap $433.77M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$10.00
Range $10.00 – $10.00
+387.8%
Consensus $10.00 vs current $2.05